Digoxin–mortality: randomized vs. observational comparison in the DIG trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Digoxin–mortality: randomized vs. observational comparison in the DIG trial
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-06-03
DOI
10.1093/eurheartj/ehz395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study
- (2019) Udo Bavendiek et al. EUROPEAN JOURNAL OF HEART FAILURE
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Digoxin and Mortality in Patients With Atrial Fibrillation
- (2018) Renato D. Lopes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial
- (2017) Alon Eisen et al. Journal of the American Heart Association
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Digoxin-associated mortality: a systematic review and meta-analysis of the literature
- (2015) Mate Vamos et al. EUROPEAN HEART JOURNAL
- Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
- (2015) Jeffrey B Washam et al. LANCET
- Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
- (2015) Oliver J Ziff et al. BMJ-British Medical Journal
- Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
- (2015) Oliver J Ziff et al. BMJ-British Medical Journal
- Digoxin in patients with permanent atrial fibrillation: Data from the RACE II study
- (2014) Bart A. Mulder et al. HEART RHYTHM
- Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial
- (2013) M. Gheorghiade et al. EUROPEAN HEART JOURNAL
- Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function
- (2013) Nileshkumar J. Patel et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Increased mortality among patients taking digoxin--analysis from the AFFIRM study
- (2012) M. G. Whitbeck et al. EUROPEAN HEART JOURNAL
- Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF)
- (2009) L. Friberg et al. HEART
- Digitalis: a dangerous drug in atrial fibrillation? An analysis of the SPORTIF III and V data
- (2007) K Gjesdal et al. HEART
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started